Brian Linscott

CIK 1807291 · View on SEC EDGAR ↗

Insider

First SEC filing: Aug. 7, 2020 · Latest: Aug. 7, 2020

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 16 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

16 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 24, 2023 HHS P 4,900 $5.57 $27,293 330,518 Direct +1.50% Acquired -27.8% (price as of 2026-08-25)
May 24, 2023 HHS P 100 $5.62 $562 330,618 Direct +0.03% Acquired -28.5% (price as of 2026-08-25)
May 8, 2023 HHS P 8,000 $5.97 $47,760 325,618 Direct +2.52% Acquired -32.7% (price as of 2026-08-25)
March 15, 2023 HHS P 2,500 $8.94 $22,350 327,443 Direct +0.77% Acquired -55.0% (price as of 2026-08-25)
Dec. 12, 2022 HHS P 2,000 $11.20 $22,400 324,443 Direct +0.62% Acquired -64.1% (price as of 2026-08-25)
Dec. 12, 2022 HHS P 500 $11.05 $5,525 324,943 Direct +0.15% Acquired -63.6% (price as of 2026-08-25)
Aug. 15, 2022 HHS P 2,000 $14.95 $29,900 196,259 Direct +1.03% Acquired -73.1% (price as of 2026-08-25)
Feb. 28, 2022 HHS P 10,000 $6.57 $65,700 318,202 Direct +3.24% Acquired -38.8% (price as of 2026-08-25)
Feb. 28, 2022 HHS P 5,000 $6.53 $32,650 323,202 Direct +1.57% Acquired -38.5% (price as of 2026-08-25)
Feb. 28, 2022 HHS P 5,000 $6.55 $32,750 328,202 Direct +1.55% Acquired -38.6% (price as of 2026-08-25)
Feb. 28, 2022 HHS P 14,100 $6.55 $92,355 342,302 Direct +4.30% Acquired -38.6% (price as of 2026-08-25)
Dec. 1, 2021 HHS P 100 $8.00 $800 294,679 Direct +0.03% Acquired -49.8% (price as of 2026-08-25)
Dec. 1, 2021 HHS P 208 $7.99 $1,662 294,887 Direct +0.07% Acquired -49.7% (price as of 2026-08-25)
Dec. 1, 2021 HHS P 92 $7.90 $727 294,979 Direct +0.03% Acquired -49.1% (price as of 2026-08-25)
Dec. 1, 2021 HHS P 100 $7.95 $795 295,079 Direct +0.03% Acquired -49.4% (price as of 2026-08-25)
Dec. 1, 2021 HHS P 3,500 $8.00 $28,000 298,579 Direct +1.19% Acquired -49.8% (price as of 2026-08-25)
Nov. 15, 2021 HHS P 5,000 $8.40 $42,000 294,579 Direct +1.73% Acquired -52.2% (price as of 2026-08-25)
Sept. 1, 2021 HHS P 3,000 $6.60 $19,800 289,579 Direct +1.05% Acquired -39.1% (price as of 2026-08-25)
Aug. 24, 2021 HHS P 1,000 $6.70 $6,700 286,579 Direct +0.35% Acquired -40.0% (price as of 2026-08-25)
Aug. 18, 2021 HHS P 300 $6.75 $2,025 284,879 Direct +0.11% Acquired -40.5% (price as of 2026-08-25)
Aug. 18, 2021 HHS P 700 $6.90 $4,830 285,579 Direct +0.25% Acquired -41.8% (price as of 2026-08-25)
Aug. 17, 2021 HHS P 5,000 $6.50 $32,500 284,579 Direct +1.79% Acquired -38.2% (price as of 2026-08-25)
June 11, 2021 HHS P 900 $6.25 $5,625 111,904 Direct +0.81% Acquired -35.7% (price as of 2026-08-25)
Dec. 9, 2020 HHS P 4,000 $2.50 $10,000 111,004 Direct +3.74% Acquired 60.8% (price as of 2026-08-25)
Dec. 7, 2020 HHS P 3,457 $2.50 $8,642 95,461 Direct +3.76% Acquired 60.8% (price as of 2026-08-25)
Dec. 7, 2020 HHS P 1,443 $2.49 $3,593 96,904 Direct +1.51% Acquired 61.4% (price as of 2026-08-25)
Dec. 7, 2020 HHS P 100 $2.42 $242 97,004 Direct +0.10% Acquired 66.1% (price as of 2026-08-25)
Dec. 7, 2020 HHS P 5,000 $2.50 $12,500 102,004 Direct +5.15% Acquired 60.8% (price as of 2026-08-25)
Dec. 7, 2020 HHS P 5,000 $2.50 $12,500 107,004 Direct +4.90% Acquired 60.8% (price as of 2026-08-25)
Dec. 4, 2020 HHS P 5,000 $2.45 $12,250 92,004 Direct +5.75% Acquired 64.0% (price as of 2026-08-25)
March 17, 2020 HHS P 2,000 $2.65 $5,300 2,000 Direct — Acquired 51.7% (price as of 2026-08-25)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 26, 2022 HHS Common Stock - Restricted Stock Units Common Stock (15,000) $8.43 May 26, 2025 15,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 7, 2020 HHS No Securities are Beneficially Ownded 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

HHS

CEO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2023 $216,346 — — — — — $725,967 $942,313
2022 $425,000 $450,000 $592,890 — — — — $1,467,890

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.